Biocon Surpasses 100 Million Insulin Cartridges Supplied To MOH
Biocon Biologics Ltd's Malaysian arm, Biocon Sdn Bhd has crossed a major milestone by supplying over 100 million cartridges of recombinant human insulin (rh-insulin) to Malaysia's Ministry of Health since 2016, benefitting more than 345,000 diabetes patients nationwide.
The insulin is produced at Biocon's state-of-the-art manufacturing facility in Johor, established with a cumulative investment of US$600 million. Recognised by the Malaysia Book of Records as the first and largest integrated insulin manufacturer in the country, the plant produces a wide range of insulins in various delivery forms.
'Every cartridge we produce at our state-of-the-art facility in Johor is a lifeline for someone living with diabetes,' said Biocon Biologics Chief Commercial Officer Susheel Umesh.
Biocon Biologics' longstanding partnership with the Ministry of Health and Duopharma Marketing Sdn. Bhd. aims to advance insulin access and healthcare resilience. Leonard Ariff Abdul Shatar, Group Managing Director of Duopharma Biotech Berhad, reaffirmed this, stating the collaboration is focused on delivering affordable, high-quality insulin to Malaysians.
Globally, Biocon Biologics is ranked among the top three producers of rh-insulin and Insulin Glargine, having delivered 9.2 billion doses to date. Related
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
New Straits Times
4 hours ago
- New Straits Times
NST Leader: Tough battle as drug trends shift
The drug scourge has been with Malaysian society for as long as we can remember. "Traditional" drugs such as ganja and heroin had dominated the scene, topping the National Anti-Drugs Agency's (AADK) annual list of substances favoured by addicts. However, last year marked a sharp shift in the trend, with synthetic drugs such as ecstasy and methamphetamine overtaking traditional drugs as the narcotics of choice. Take the latest troubling statistics: Of the 193,000 addicts arrested or who voluntarily surrendered, 60 per cent were hooked on synthetics, outpacing heroin and ganja abuse. They were attracted to the drugs because of easy access, lower prices and more potent effects. AADK director-general Datuk Ruslin Jusoh, in an interview with the New Straits Times, said synthetic drugs have become the favoured narcotics of the younger generation, namely addicts aged between 19 and 39. They make up almost 70 per cent of those hooked on synthetic drugs. Why this shift to synthetics? It's a complex mix of social, psychological, economic and environmental factors. There's the party and clubbing culture: drug-using peers increase exposure and favourable attitudes, thrill-seeking and experimentation. There's also the misplaced perception that synthetics are "safe and legal" because peddlers' market them as "legal highs", labelling products as "incense" and "potpourri" to mislead users. The downside is severe and unpredictable side-effects: trauma, mental health problems, family conflict, stress and poor self-image. Another effect of the popularity of synthetic drugs, according to Roslin, is the perception among youths that ganja is a "safer" option. This has inadvertently fulfilled the age-old adage of ganja being a gateway drug, looping in fledgling users to experiment with stronger, more potent narcotics. Hindsight, they say, is 20-20. Given current developments, it would appear that Malaysia has dodged a bullet when a 2022 movement to legalise "medical" marjuana in the country failed to take off. Even Thailand, which had decriminalised marijuana in 2022 — a first for Southeast Asia — this week reimposed restrictions on the drug. All these only serve to underscore the harsh reality that despite decades of government and community approach involving education, early intervention, treatment and support, eradicating drugs is a monumental battle. While the temptation to capitalise on the potential economic benefits is there, it is undoubtedly too high a price to pay.
The Star
7 hours ago
- The Star
Health workers in Cambodia on standby to support military, citizens on Thai border
Cambodian Health Minister Chheang Ra (centre) inspects medical facilities in Preah Vihear province on the Cambodia-Thailand border. - Phnom Penh Post/ANN PHNOM PENH (Phnom Penh Post/ANN): The Cambodian Ministry of Health has deployed additional staff and stockpiled medical supplies to strengthen more than 120 health centres along the border. The beefed up clinics and centres aim to assist local citizens — as well as military personnel — along the Cambodia–Thailand border, following the recent resumption of border clashes. During an inspection tour of the border area of Preah Vihear province on June 28 and 29, Minister of Health Chheang Ra stated that after the incident on May 28, which involved an exchange of fire between Cambodian and Thai troops, medical teams were immediately deployed to the border areas, particularly the Techo Bos Sbov area. The teams also began inspecting health centres and community health bases along the border, from Preah Vihear province to Oddar Meanchey, Banteay Meanchey, Battambang, Pailin, Pursat and Koh Kong. 'The health ministry stands with our people and the troops defending our nation's territory. All local-level institutions are working together in solidarity,' the minister stated. He explained that the ministry has launched a special campaign, conducting regular inspections of health centres, but noted that due to the current border dispute, they are also delivering additional medicines and supplies to health centres, while assessing the wellbeing of local people. 'The local health centres and posts along the Cambodia–Thailand border are not isolated. Medical teams across the country are mobilising to stand with our people. We are preparing teams to be ready for any situation. We've come to assess the situation so we can be even better prepared,' he said. The minister added that the ministry has reinforced over 120 health centres along the border, in addition to seven provincial referral hospitals and a facility in Siem Reap province. 'We have seen that our people are well-prepared, with sufficient medicines and equipment. Our staff are ready to mobilise, performing their daily duties and able to respond immediately when needed. This shows that our people are warm-hearted and well-prepared, and we hope citizens will continue to receive even better services,' he said. During the two-day inspection trip, the minister also met with and provided donations to internally displaced people temporarily staying at Wat Po 5000 — over 5,000 individuals from 2,264 families. The ministry stated that Ra advised the leadership of medical agencies at all levels to collaborate in providing both technical and treatment assistance, while further clarifying and deepening their understanding of the situation. In addition, they must evaluate the outcomes of expanded hospital capacity — particularly focusing on emergency response services, treatment beds, and effective referral systems. He explained that responsible leaders must accelerate the strengthening of district hospital capacity in border areas for emergency services, and they must closely monitor the progress of this work to ensure full readiness for delivering emergency and trauma care in critical situations. - Phnom Penh Post/Asia News Network
Barnama
9 hours ago
- Barnama
Pharma Industry Emerging As Driver Of Investments, Jobs, And Healthcare Resilience -- MPC
BUSINESS KUALA LUMPUR, June 30 (Bernama) -- Malaysia's pharmaceutical industry is emerging as a driver of high-value investment, skilled employment, and healthcare resilience, driven by regulatory and productivity reforms implemented in recent years, according to the Malaysia Productivity Corporation (MPC). MPC said these efforts have also supported Malaysia's climb to 23rd place in the 2025 International Institute for Management Development (IMD) World Competitiveness Ranking, the country's highest position in over a decade. 'Under the MPC, the Pharmaceutical Productivity Nexus (PPN) has driven structural changes that translate directly into economic value by streamlining product registration processes, aligning technical requirements across agencies, and reducing regulatory bottlenecks,' it said in a statement today. According to the MPC, two new pharmaceutical facilities have progressed to the development stage, unlocking investments and creating skilled employment opportunities, while two additional facilities are moving forward more rapidly under the streamlined processes. MPC director general Datuk Zahid Ismail said the sector's transformation provides a blueprint for national economic renewal. 'Every bottleneck removed is an opportunity unlocked, whether it's faster factory approvals, increased export readiness, or local production of critical medicines,' he added. The president of the Malaysian Organisation of Pharmaceutical Industries (MOPI) and PPN representative, Ch'ng Kien Peng, said the pharmaceutical sector's gains reflect what is possible when productivity reforms are targeted, data-driven, and collaborative. 'These wins go beyond industry metrics. They mean better access to affordable medicines, more quality jobs for Malaysians, and increased resilience in our healthcare supply chain,' he said. The MPC also stated that the sector's progress aligns with the objectives of the 12th Malaysia Plan, the New Industrial Master Plan 2030, and the National Energy Transition Roadmap by supporting economic growth and localised production of essential medicines while integrating environmental sustainability practices in facility operations. It added that continued investment in automation, digitalisation, and skills development by industry players will help sustain these gains, while support from the government in advancing mutual recognition agreements and inter-agency frameworks remains important to maintain momentum in the sector. --BERNAMA
